Answer
In a clinical study, oral tedizolid phosphate 200 mg once daily increased single-dose rosuvastatin 10 mg AUC by approximately 70% and Cmax by 55%, indicating potential intestinal BCRP inhibition.
Sources for this answer
- Sivextro 200 mg powder for concentrate for solution for infusionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 15Document updated
Sources checked